Intakes of caffeine, coffee and tea and risk of amyotrophic lateral sclerosis: Results from five cohort studies

References

• Palacios N, Gao X, McCullough ML, Schwarzschild MA, Shah R, Gapstur S, et al. Caffeine and risk of Parkinson’s disease in a large cohort of males and females. Mov Disord. 2012;27:1276–82.
   PubMed Web of Science ®Google Scholar
• Ascherio A, Weisskopf MG, O’Reilly EJ, McCullough ML, Calle EE, Rodriguez C, et al. Coffee consumption, gender, and Parkinson’s disease mortality in the cancer prevention study II cohort: the modifying effects of estrogen. Am J Epidemiol. 2004;160:977–84.
   PubMed Web of Science ®Google Scholar
• Ross GW, Abbott RD, Petrovitch H, Morens DM, Grandinetti A, Tung H, et al. Association of coffee and caffeine intake with the risk of Parkinson’s disease. JAMA. 2000;283:2674–9.
   PubMed Web of Science ®Google Scholar
• Hu G, Bidel S, Jousilahti P, Antikainen R, Tuomilehto J. Coffee and tea consumption and the risk of Parkinson’s disease. Mov Disord. 2007;22:2242–8.
   PubMed Web of Science ®Google Scholar
• Saaksjarvi K, Knekt P, Rissanen H, Laaksonen MA, Reunanen A, Mannisto S. Prospective study of coffee consumption and risk of Parkinson’s disease. Eur J Clin Nutr. 2008;62:908–15.
   PubMed Web of Science ®Google Scholar
• Liu R, Guo X, Park Y, Huang X, Sinha R, Freedman ND, et al. Caffeine intake, smoking, and risk of Parkinson’s disease in males and females. Am J Epidemiol. 2012; 175:1200–7.
   PubMed Web of Science ®Google Scholar
• Chen JF, Xu K, Petzer JP, Staal R, Xu YH, Beilstein M, et al. Neuroprotection by caffeine and A(2A) adenosine receptor inactivation in a model of Parkinson’s disease. J Neurosci. 2001;21:RC143.
   PubMed Web of Science ®Google Scholar
• van den Bosch L, van Damme P, Bogaert E, Robberecht W. The role of excitotoxicity in the pathogenesis of amyotrophic lateral sclerosis. Biochim Biophys Acta. 2006;1762: 1068–82.
   PubMed Web of Science ®Google Scholar
• Beghi E, Pupillo E, Messina P, Giussani G, Chio A, Zoccolella S, et al. Coffee and amyotrophic lateral sclerosis: a possible preventive role. Am J Epidemiol. 2011;174: 1002–8.
   PubMed Web of Science ®Google Scholar
• Fondell E, O’Reilly EJ, Fitzgerald KC, Falcone GJ, McCullough ML, Park Y, et al. Magnesium intake and risk of amyotrophic lateral sclerosis: results from five large cohort studies. Amyotroph Lateral Scler Frontotemporal Degener. 2013;14:356–61.
   PubMed Web of Science ®Google Scholar
• Weisskopf MG, McCullough ML, Calle EE, Thun MJ, Cudkowicz M, Ascherio A. Prospective study of cigarette smoking and amyotrophic lateral sclerosis. Am J Epidemiol. 2004;160:26–33.
   PubMed Web of Science ®Google Scholar
• del Aguila MA, Longstreth Jr WT, McGuire V, Koepsell TD, van Belle G. Prognosis in amyotrophic lateral sclerosis: a population based study. Neurology. 2003;60:813–9.
   PubMed Web of Science ®Google Scholar
• Sorenson EJ, Stalker AP, Kurland LT, Windebank AJ. Amyotrophic lateral sclerosis in Olmsted County, Minnesota, 1925–1998. Neurology. 2002;59:280–2.
   Google Scholar
• Magnus T, Beck M, Giess R, Puls I, Naumann M, Toyka KV. Disease progression in amyotrophic lateral sclerosis: predictors of survival. Muscle & Nerve. 2002;25:709–14.
   PubMed Web of Science ®Google Scholar
• Colditz GA, Manson JE, Hankinson SE. The Nurses’ Health Study: 20-year contribution to the understanding of health among females. J Womens Health. 1997;6:49–62.
   PubMed Web of Science ®Google Scholar
• Rimm EB, Giovannucci EL, Willett WC, Colditz GA, Ascherio A, Rosner B, et al. Prospective study of alcohol consumption and risk of coronary disease in males. Lancet. 1991;338:464–8.
   PubMed Web of Science ®Google Scholar
• Calle EE, Rodriguez C, Jacobs EJ, Almon ML, Chao A, McCullough ML, et al. The American Cancer Society Cancer Prevention Study II Nutrition Cohort: rationale, study design, and baseline characteristics. Cancer. 2002;94: 2490–501.
   PubMed Web of Science ®Google Scholar
• Kolonel LN, Henderson BE, Hankin JH, Nomura AM, Wilkens LR, Pike MC, et al. A multiethnic cohort in Hawaii and Los Angeles: baseline characteristics. Am J Epidemiol. 2000;151:346–57.
   PubMed Web of Science ®Google Scholar
• Schatzkin A, Subar AF, Thompson FE, Harlan LC, Tangrea J, Hollenbeck AR, et al. Design and serendipity in establishing a large cohort with wide dietary intake distributions: the National Institutes of Health–American Association of Retired Persons Diet and Health Study. Am J Epidemiol. 2001;154:1119–25.
   PubMed Web of Science ®Google Scholar
• Flagg EW, Coates RJ, Calle EE, Potischman N, Thun MJ. Validation of the American Cancer Society Cancer Prevention Study II Nutrition Survey Cohort Food Frequency Questionnaire. Epidemiology. 2000;11:462–8.
   PubMed Web of Science ®Google Scholar
• Salvini S, Hunter DJ, Sampson L, Stampfer MJ, Colditz GA, Rosner B, et al. Food-based validation of a dietary questionnaire: the effects of week-to-week variation in food consumption. Int J Epidemiol. 1989;18:858–67.
   PubMed Web of Science ®Google Scholar
• Grobbee DE, Rimm EB, Giovannucci E, Colditz G, Stampfer M, Willett W. Coffee, caffeine, and cardiovascular disease in males. N Engl J Med. 1990;323:1026–32.
   PubMed Web of Science ®Google Scholar
• Freedman ND, Park Y, Abnet CC, Hollenbeck AR, Sinha R. Association of coffee drinking with total and cause-specific mortality. N Engl J Med. 2012;366:1891–904.
   PubMed Web of Science ®Google Scholar
• Thompson FE, Kipnis V, Midthune D, Freedman LS, Carroll RJ, Subar AF, et al. Performance of a food-frequency questionnaire in the US NIH-AARP (National Institutes of Health-American Association of Retired Persons) Diet and Health Study. Public Health Nutr. 2008;11:183–95.
   PubMed Web of Science ®Google Scholar
• Wang H, O’Reilly EJ, Weisskopf MG, Logroscino G, McCullough ML, Thun MJ, et al. Smoking and risk of amyotrophic lateral sclerosis: a pooled analysis of five prospective cohorts. Arch Neurol. 2011;68:207–13.
   PubMed Web of Science ®Google Scholar
• Wang H, O’Reilly EJ, Weisskopf MG, Logroscino G, McCullough ML, Schatzkin A, et al. Vitamin E intake and risk of amyotrophic lateral sclerosis: a pooled analysis of data from five prospective cohort studies. Am J Epidemiol. 2011;173:595–602.
   PubMed Web of Science ®Google Scholar
• Fitzgerald KC, O’Reilly EJ, Falcone GJ, McCullough ML, Park Y, Kolonel LN, et al. Dietary omega-3 polyunsaturated fatty acid intake and risk for amyotrophic lateral sclerosis. JAMA Neurol. 2014;71:1102–10.
   PubMed Web of Science ®Google Scholar
• Fitzgerald KC, O’Reilly EJ, Fondell E, Falcone GJ, McCullough ML, Park Y, et al. Intakes of vitamin C and carotenoids and risk of amyotrophic lateral sclerosis: pooled results from five cohort studies. Ann Neurol. 2013;73: 236–45.
   PubMed Web of Science ®Google Scholar
• Potenza RL, Armida M, Ferrante A, Pezzola A, Matteucci A, Puopolo M, et al. Effects of chronic caffeine intake in a mouse model of amyotrophic lateral sclerosis. J Neurosci Res. 2013;91:585–92.
   PubMed Web of Science ®Google Scholar
• Ascherio A, Zhang SM, Hernan MA, Kawachi I, Colditz GA, Speizer FE, et al. Prospective study of caffeine consumption and risk of Parkinson’s disease in males and females. Ann Neurol. 2001;50:56–63.
   PubMed Web of Science ®Google Scholar
• van Dam RM, Willett WC, Manson JE, Hu FB. Coffee, caffeine, and risk of type 2 diabetes: a prospective cohort study in younger and middle-aged U.S. females. Diabetes Care. 2006;29:398–403.
   PubMed Web of Science ®Google Scholar
• Doo T, Morimoto Y, Steinbrecher A, Kolonel LN, Maskarinec G. Coffee intake and risk of type 2 diabetes: the Multiethnic Cohort. Public Health Nutr. 2014;17:1328–36.
   PubMed Web of Science ®Google Scholar
• Logroscino G, Traynor BJ, Hardiman O, Chio A, Couratier P, Mitchell JD, et al. Descriptive epidemiology of amyotrophic lateral sclerosis: new evidence and unsolved issues. J Neurol Neurosurg Psychiatry. 2008;79:6–11.
   PubMed Web of Science ®Google Scholar
• Armon C. An evidence-based medicine approach to the evaluation of the role of exogenous risk factors in sporadic amyotrophic lateral sclerosis. Neuroepidemiology. 2003; 22:217–28.
   PubMed Web of Science ®Google Scholar
• Hoffman PM, Brody JA. The reliability of death certificate reporting for amyotrophic lateral sclerosis. J Chronic Dis. 1971;24:5–8.
   PubMedGoogle Scholar
• Chio A. Risk factors in the early diagnosis of ALS: European epidemiological studies. Amyotroph Lateral Scler Other Motor Neuron Disord. 2000;(Suppl 1):S13–8.
   PubMedGoogle Scholar
• Yeo L, Lynch C, Hardiman O. Validating population-based registers for ALS: how accurate is death certification? J Neurol. 2010;257:1235–9.
   PubMed Web of Science ®Google Scholar